Arch Therapeutics Inc (ARTH)

[21money21]

Sounds like maryfallon missed the buying opportunity yest and wants another chance. Look, we all know Arth doesn't have a lot of cash. That's why I bet we hear of partnership soon. If not, eventually will have to dilute for more trials and fda. Results were great and no reason to believe next trials won't be just as good if not better. So we go it alone and reap all of the spoils although everything will be slow moving or we partner and really get the ball rolling. This is all known Mary. Come up with something else